FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review Read more
FDA Approves Genentech’s Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older Read more
Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market Read more
FDA Approves GSK’s BLENREP for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Read more
Evotec and Secarna Pharmaceuticals form strategic partnership in the field of antisense therapy Read more
J&J Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine Read more
LORBRENA (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer Read more